Skip to Content
Morningstar

Xtrackers MSCI All World exUS Hdg Eq ETF DBAW

Morningstar Medalist Rating
Medalist Rating as of | See Xtrackers Investment Hub

Morningstar’s Analysis DBAW

Will DBAW outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Process Pillar

The Process Pillar is our assessment of how sensible, clearly defined, and repeatable DBAW’s performance objective and investment process is for both security selection and portfolio construction.

People Pillar

The People Pillar is our evaluation of the DBAW management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

Parent Pillar

The Parent Pillar is our rating of DBAW’s parent organization’s priorities and whether they’re in line with investors’ interests.

Xtrackers MSCI All World exUS Hdg Eq ETF’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings DBAW

More DBAW Holdings
  • Current Portfolio Date
  • Equity Holdings 1978
  • Bond Holdings 0
  • Other Holdings 86
  • % Assets in Top 10 Holdings 11.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Currency Contract - Usd

124.69
172,922,049
Derivative

Currency Contract - Inr

8.26
11,451,414
Derivative

Currency Contract - Twd

8.12
11,262,212
Derivative

Currency Contract - Krw

6.63
9,198,542
Derivative

Currency Contract - Brl

2.95
4,094,514
Derivative

Deutsche Gov Mm Ser Inst 2403 Cdw

2.36
3,278,557
Cash and Equivalents

Taiwan Semiconductor Manufacturing Co Ltd

1.79
2,486,340
Technology

MSCI EAFE Index Future Dec 23

1.61
2,238,075
—

Novo Nordisk A/S Class B

1.30
1,806,583
Healthcare

Nestle SA

1.21
1,678,035
Consumer Defensive